Skip to main content
OpenTrials

Clinical trial condition

HER2-negative Breast Cancer

Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

109 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

HER2-negative Breast Cancer trial results

Recruiting

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

NCT05029999

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +5 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

NCT07483307

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

NCT06678269

Conditions
Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

NCT01042379

Conditions
Angiosarcoma, Breast Cancer, Breast Diseases, +24 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of California - Davis, Comprehensive Cancer Center Davis, California, United States
View all 42 locations
View Trial Details
Recruiting

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

NCT05982093

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • ICO Badalona Badalona, Barcelona, Spain
  • ICO Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitari Arnau de Vilanova de Lleida Vilanova, Lleida, Spain
  • Hospital Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain
View all 15 locations
View Trial Details

Related conditions